Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Renal Impairment Compared to Healthy Participants.
Clinical trial NCT05282030 · COMPLETED
Trial details
- NCT number
- NCT05282030
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-10
- Primary completion
- 2022-08-02
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.